Citigroup’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.05M Sell
48,767
-8,751
-15% -$188K ﹤0.01% 2494
2025
Q1
$1.31M Buy
57,518
+398
+0.7% +$9.09K ﹤0.01% 2377
2024
Q4
$1.48M Buy
57,120
+11,140
+24% +$289K ﹤0.01% 2322
2024
Q3
$1.15M Buy
45,980
+20,050
+77% +$502K ﹤0.01% 2463
2024
Q2
$556K Buy
25,930
+1,875
+8% +$40.2K ﹤0.01% 2631
2024
Q1
$446K Buy
24,055
+3,515
+17% +$65.2K ﹤0.01% 2931
2023
Q4
$334K Buy
20,540
+7,578
+58% +$123K ﹤0.01% 2938
2023
Q3
$179K Sell
12,962
-17,560
-58% -$243K ﹤0.01% 3028
2023
Q2
$675K Buy
30,522
+15,109
+98% +$334K ﹤0.01% 2528
2023
Q1
$335K Sell
15,413
-5,004
-25% -$109K ﹤0.01% 2817
2022
Q4
$372K Buy
20,417
+4,319
+27% +$78.6K ﹤0.01% 2710
2022
Q3
$366K Buy
16,098
+2,528
+19% +$57.5K ﹤0.01% 2785
2022
Q2
$187K Sell
13,570
-11,354
-46% -$156K ﹤0.01% 3226
2022
Q1
$567K Buy
24,924
+6,937
+39% +$158K ﹤0.01% 2769
2021
Q4
$670K Buy
17,987
+3,098
+21% +$115K ﹤0.01% 2872
2021
Q3
$630K Buy
14,889
+13,246
+806% +$560K ﹤0.01% 2741
2021
Q2
$73K Buy
1,643
+330
+25% +$14.7K ﹤0.01% 3970
2021
Q1
$47K Sell
1,313
-1,843
-58% -$66K ﹤0.01% 4075
2020
Q4
$126K Buy
3,156
+2,293
+266% +$91.5K ﹤0.01% 3526
2020
Q3
$25K Sell
863
-383
-31% -$11.1K ﹤0.01% 3815
2020
Q2
$20K Sell
1,246
-2,046
-62% -$32.8K ﹤0.01% 4230
2020
Q1
$31K Buy
3,292
+1,737
+112% +$16.4K ﹤0.01% 4114
2019
Q4
$25K Buy
1,555
+783
+101% +$12.6K ﹤0.01% 4384
2019
Q3
$13K Sell
772
-1,097
-59% -$18.5K ﹤0.01% 4451
2019
Q2
$32K Sell
1,869
-17,950
-91% -$307K ﹤0.01% 4356
2019
Q1
$355K Buy
+19,819
New +$355K ﹤0.01% 2737
2015
Q3
Sell
-30
Closed 5225
2015
Q2
$0 Buy
30
+29
+2,900% ﹤0.01% 5527
2015
Q1
$0 Sell
1
-373
-100% ﹤0.01% 5471
2014
Q4
$1K Buy
374
+276
+282% +$738 ﹤0.01% 5299
2014
Q3
$0 Buy
+98
New ﹤0.01% 5400